When Ruth Chepngetich shattered the women’s marathon world record at the Chicago Marathon two years ago with a time of 2 hours, 9 minutes, and 56 seconds, her performance was immediately hailed as revolutionary. The Kenyan athlete not only broke the previous record by nearly two minutes but also improved her personal best by five minutes, prompting commentators to liken her achievement to historic milestones in sport.

However, the celebration was short-lived. Five months after her record-setting run, Chepngetich tested positive for a banned substance and was subsequently banned from competition for three years. Despite this suspension, her world record remains officially recognized, as she passed doping tests conducted immediately after the race.

This situation has raised questions about the integrity of the record and the broader implications for athletics. Brett Clothier, head of the Athletics Integrity Unit (AIU), which prosecuted Chepngetich’s case, acknowledged in a recent discussion that the current state of affairs is unsatisfactory. However, he emphasized that the World Anti-Doping Code protects athletes' rights, particularly when there is no direct evidence of doping at the time of their performance.

Chepngetich tested positive for hydrochlorothiazide (HCTZ), a diuretic often used as a masking agent, at levels 20 times the legal limit. Her explanation was that she had taken her housemaid’s medication after experiencing symptoms such as feeling hot and a rapid heartbeat—a claim the AIU termed “hardly credible.” Further intensifying concerns, investigators found messages on Chepngetich's phone referencing the banned drug testosterone and communications suggesting involvement with unidentified third parties potentially connected to doping programs. Chepngetich has denied ever using testosterone and characterized the messages as part of a group chat.

The ongoing debate echoes historical controversies in athletics, such as the suspicious records set during the 1980s and 1990s, often linked to state-sponsored doping programs in certain countries. Yet Chepngetich’s case is notable because no other athlete has faced a comparable ban so soon after setting a world record.

Experts consulted by officials have concluded that removing Chepngetich’s record retroactively could conflict with legal principles, including proportionality and human rights, without clear evidence of doping at the time of the record. Comparisons have been drawn to high-profile doping cases like Lance Armstrong, who was stripped of his Tour de France titles years after competition, but regulatory bodies maintain that Armstrong’s case is not easily transferable due to procedural differences.

Ideas proposed to address such cases include implementing “social contracts,” which would require athletes to forfeit titles or records if they test positive within a set period after a major achievement. However, changing global anti-doping regulations to accommodate such measures would require broad consensus among sporting, governmental, and human rights organizations—a prospect currently deemed unlikely.

Despite these challenges, progress continues in athletics’ fight against doping. Since its establishment in 2017, the AIU has sanctioned 317 elite Kenyan athletes, demonstrating active enforcement on a relatively modest annual budget. Sponsors are also increasingly investing in enhanced drug testing. For example, Adidas and Nike have funded additional screenings ahead of significant marathon events, signaling a commitment to clean competition.

Additionally, some agents are exploring contractual commitments that would require athletes to return prize money if found guilty of doping. These initiatives reflect a growing awareness within the sport’s community that stronger safeguards are necessary to uphold athletics’ credibility, even as Chepngetich’s record remains a contentious symbol.